Identification and characterization of a novel mutation in von Willebrand factor causing type 2B von Willebrand's disease
Type 2B von Willebrand's disease (VWD) is a variant in which the structurally abnormal von Willebrand factor (VWF) has an increased affinity for the platelet glycoprotein Ib–IX–V complex. Spontaneous binding of type 2B VWF to platelets and their subsequent clearance from the plasma appear to ac...
Gespeichert in:
Veröffentlicht in: | British journal of haematology 1999-05, Vol.105 (2), p.538-541 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 541 |
---|---|
container_issue | 2 |
container_start_page | 538 |
container_title | British journal of haematology |
container_volume | 105 |
creator | Facey, David A. Favaloro, Emmanuel J. Koutts, Jerry Berndt, Michael C. Hertzberg, Mark S. |
description | Type 2B von Willebrand's disease (VWD) is a variant in which the structurally abnormal von Willebrand factor (VWF) has an increased affinity for the platelet glycoprotein Ib–IX–V complex. Spontaneous binding of type 2B VWF to platelets and their subsequent clearance from the plasma appear to account for the characteristic phenotype of type 2B VWD. Several type 2B mutations have been described and shown to be grouped along the amino edge of the beta sheet of the VWF A1 domain. In this report we describe a novel missense mutation, Arg543Leu, in the VWF A1 domain in three members of a family with type 2B VWD. We have expressed and characterized the corresponding recombinant mutant VWF in transiently transfected COS‐7 cells. Relative to wild‐type VWF, recombinant Arg543Leu VWF showed a similar multimer composition but exhibited binding to fixed platelets both in the presence and absence of ristocetin, confirming the ability of this mutation to permit spontaneous interaction of VWF with platelets. These studies are consistent with a recently proposed model in which the VWF‐A1 domain exists in either ‘on’ or ‘off’ states, with type 2B mutations switching VWF to an ‘on’ state to facilitate GPIb binding. |
doi_str_mv | 10.1111/j.1365-2141.1999.01358.x |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69774982</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>41823800</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3188-a41fe15f9cb5f771d2290aa72f50a39d64a9154e254ccfc8c848c12c80fffc8e3</originalsourceid><addsrcrecordid>eNqNkUtv1DAURq0K1E5L_0JlIURXCb5-jO0FC1rRB6rEBsTS8jg2eJRJBjspHX49TjMqqCu8uX6c79ryQQgDqaGMd-sa2FJUFDjUoLWuCTCh6ocDtHg6eIEWhBBZAeHqCB3nvCaFIgIO0REQyhhnfIF2t43vhhiis0PsO2y7BrsfNlk3-BR_z5t9wBZ3_b1v8WYc5r3Y4ftSvsW29as0xULJ9Ak7O-bYfcfDbusxvXhGnWfcxOxt9q_Qy2Db7E_39QR9vfr45fKmuvt8fXv54a5yDJSqLIfgQQTtViJICQ2lmlgraRDEMt0sudUguKeCOxeccoorB9QpEkJZenaC3s59t6n_Ofo8mE3Mzret7Xw_ZrPUUnKtaAFfPwPX_Zi68jYDWglNKCwLpGbIpT7n5IPZprixaWeAmMmNWZtJgZkUmMmNeXRjHkr0bN9_XG18809wllGAN3vAZmfbUP7LxfyXk1JTKQv2fsZ-xdbv_vt-c_HpZpqxPzB3quw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>198590216</pqid></control><display><type>article</type><title>Identification and characterization of a novel mutation in von Willebrand factor causing type 2B von Willebrand's disease</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Wiley Free Content</source><creator>Facey, David A. ; Favaloro, Emmanuel J. ; Koutts, Jerry ; Berndt, Michael C. ; Hertzberg, Mark S.</creator><creatorcontrib>Facey, David A. ; Favaloro, Emmanuel J. ; Koutts, Jerry ; Berndt, Michael C. ; Hertzberg, Mark S.</creatorcontrib><description>Type 2B von Willebrand's disease (VWD) is a variant in which the structurally abnormal von Willebrand factor (VWF) has an increased affinity for the platelet glycoprotein Ib–IX–V complex. Spontaneous binding of type 2B VWF to platelets and their subsequent clearance from the plasma appear to account for the characteristic phenotype of type 2B VWD. Several type 2B mutations have been described and shown to be grouped along the amino edge of the beta sheet of the VWF A1 domain. In this report we describe a novel missense mutation, Arg543Leu, in the VWF A1 domain in three members of a family with type 2B VWD. We have expressed and characterized the corresponding recombinant mutant VWF in transiently transfected COS‐7 cells. Relative to wild‐type VWF, recombinant Arg543Leu VWF showed a similar multimer composition but exhibited binding to fixed platelets both in the presence and absence of ristocetin, confirming the ability of this mutation to permit spontaneous interaction of VWF with platelets. These studies are consistent with a recently proposed model in which the VWF‐A1 domain exists in either ‘on’ or ‘off’ states, with type 2B mutations switching VWF to an ‘on’ state to facilitate GPIb binding.</description><identifier>ISSN: 0007-1048</identifier><identifier>EISSN: 1365-2141</identifier><identifier>DOI: 10.1111/j.1365-2141.1999.01358.x</identifier><identifier>PMID: 10233434</identifier><identifier>CODEN: BJHEAL</identifier><language>eng</language><publisher>Oxford, U.K. and Cambridge, USA: Blackwell Science Ltd</publisher><subject>Biological and medical sciences ; Female ; Hematologic and hematopoietic diseases ; Hematology ; Hemostasis ; Heterozygote ; Humans ; Medical sciences ; Middle Aged ; mutation ; Mutation, Missense - genetics ; Platelet diseases and coagulopathies ; recombinant ; von Willebrand Diseases - blood ; von Willebrand Diseases - genetics ; von Willebrand Factor - genetics ; VWD type 2B ; VWF</subject><ispartof>British journal of haematology, 1999-05, Vol.105 (2), p.538-541</ispartof><rights>1999 INIST-CNRS</rights><rights>Copyright Blackwell Scientific Publications Ltd. May 1999</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3188-a41fe15f9cb5f771d2290aa72f50a39d64a9154e254ccfc8c848c12c80fffc8e3</citedby><cites>FETCH-LOGICAL-c3188-a41fe15f9cb5f771d2290aa72f50a39d64a9154e254ccfc8c848c12c80fffc8e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1365-2141.1999.01358.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1365-2141.1999.01358.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,1412,1428,27905,27906,45555,45556,46390,46814</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1779277$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10233434$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Facey, David A.</creatorcontrib><creatorcontrib>Favaloro, Emmanuel J.</creatorcontrib><creatorcontrib>Koutts, Jerry</creatorcontrib><creatorcontrib>Berndt, Michael C.</creatorcontrib><creatorcontrib>Hertzberg, Mark S.</creatorcontrib><title>Identification and characterization of a novel mutation in von Willebrand factor causing type 2B von Willebrand's disease</title><title>British journal of haematology</title><addtitle>Br J Haematol</addtitle><description>Type 2B von Willebrand's disease (VWD) is a variant in which the structurally abnormal von Willebrand factor (VWF) has an increased affinity for the platelet glycoprotein Ib–IX–V complex. Spontaneous binding of type 2B VWF to platelets and their subsequent clearance from the plasma appear to account for the characteristic phenotype of type 2B VWD. Several type 2B mutations have been described and shown to be grouped along the amino edge of the beta sheet of the VWF A1 domain. In this report we describe a novel missense mutation, Arg543Leu, in the VWF A1 domain in three members of a family with type 2B VWD. We have expressed and characterized the corresponding recombinant mutant VWF in transiently transfected COS‐7 cells. Relative to wild‐type VWF, recombinant Arg543Leu VWF showed a similar multimer composition but exhibited binding to fixed platelets both in the presence and absence of ristocetin, confirming the ability of this mutation to permit spontaneous interaction of VWF with platelets. These studies are consistent with a recently proposed model in which the VWF‐A1 domain exists in either ‘on’ or ‘off’ states, with type 2B mutations switching VWF to an ‘on’ state to facilitate GPIb binding.</description><subject>Biological and medical sciences</subject><subject>Female</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Hematology</subject><subject>Hemostasis</subject><subject>Heterozygote</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>mutation</subject><subject>Mutation, Missense - genetics</subject><subject>Platelet diseases and coagulopathies</subject><subject>recombinant</subject><subject>von Willebrand Diseases - blood</subject><subject>von Willebrand Diseases - genetics</subject><subject>von Willebrand Factor - genetics</subject><subject>VWD type 2B</subject><subject>VWF</subject><issn>0007-1048</issn><issn>1365-2141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkUtv1DAURq0K1E5L_0JlIURXCb5-jO0FC1rRB6rEBsTS8jg2eJRJBjspHX49TjMqqCu8uX6c79ryQQgDqaGMd-sa2FJUFDjUoLWuCTCh6ocDtHg6eIEWhBBZAeHqCB3nvCaFIgIO0REQyhhnfIF2t43vhhiis0PsO2y7BrsfNlk3-BR_z5t9wBZ3_b1v8WYc5r3Y4ftSvsW29as0xULJ9Ak7O-bYfcfDbusxvXhGnWfcxOxt9q_Qy2Db7E_39QR9vfr45fKmuvt8fXv54a5yDJSqLIfgQQTtViJICQ2lmlgraRDEMt0sudUguKeCOxeccoorB9QpEkJZenaC3s59t6n_Ofo8mE3Mzret7Xw_ZrPUUnKtaAFfPwPX_Zi68jYDWglNKCwLpGbIpT7n5IPZprixaWeAmMmNWZtJgZkUmMmNeXRjHkr0bN9_XG18809wllGAN3vAZmfbUP7LxfyXk1JTKQv2fsZ-xdbv_vt-c_HpZpqxPzB3quw</recordid><startdate>199905</startdate><enddate>199905</enddate><creator>Facey, David A.</creator><creator>Favaloro, Emmanuel J.</creator><creator>Koutts, Jerry</creator><creator>Berndt, Michael C.</creator><creator>Hertzberg, Mark S.</creator><general>Blackwell Science Ltd</general><general>Blackwell</general><general>Blackwell Publishing Ltd</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>199905</creationdate><title>Identification and characterization of a novel mutation in von Willebrand factor causing type 2B von Willebrand's disease</title><author>Facey, David A. ; Favaloro, Emmanuel J. ; Koutts, Jerry ; Berndt, Michael C. ; Hertzberg, Mark S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3188-a41fe15f9cb5f771d2290aa72f50a39d64a9154e254ccfc8c848c12c80fffc8e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Biological and medical sciences</topic><topic>Female</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Hematology</topic><topic>Hemostasis</topic><topic>Heterozygote</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>mutation</topic><topic>Mutation, Missense - genetics</topic><topic>Platelet diseases and coagulopathies</topic><topic>recombinant</topic><topic>von Willebrand Diseases - blood</topic><topic>von Willebrand Diseases - genetics</topic><topic>von Willebrand Factor - genetics</topic><topic>VWD type 2B</topic><topic>VWF</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Facey, David A.</creatorcontrib><creatorcontrib>Favaloro, Emmanuel J.</creatorcontrib><creatorcontrib>Koutts, Jerry</creatorcontrib><creatorcontrib>Berndt, Michael C.</creatorcontrib><creatorcontrib>Hertzberg, Mark S.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>British journal of haematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Facey, David A.</au><au>Favaloro, Emmanuel J.</au><au>Koutts, Jerry</au><au>Berndt, Michael C.</au><au>Hertzberg, Mark S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Identification and characterization of a novel mutation in von Willebrand factor causing type 2B von Willebrand's disease</atitle><jtitle>British journal of haematology</jtitle><addtitle>Br J Haematol</addtitle><date>1999-05</date><risdate>1999</risdate><volume>105</volume><issue>2</issue><spage>538</spage><epage>541</epage><pages>538-541</pages><issn>0007-1048</issn><eissn>1365-2141</eissn><coden>BJHEAL</coden><abstract>Type 2B von Willebrand's disease (VWD) is a variant in which the structurally abnormal von Willebrand factor (VWF) has an increased affinity for the platelet glycoprotein Ib–IX–V complex. Spontaneous binding of type 2B VWF to platelets and their subsequent clearance from the plasma appear to account for the characteristic phenotype of type 2B VWD. Several type 2B mutations have been described and shown to be grouped along the amino edge of the beta sheet of the VWF A1 domain. In this report we describe a novel missense mutation, Arg543Leu, in the VWF A1 domain in three members of a family with type 2B VWD. We have expressed and characterized the corresponding recombinant mutant VWF in transiently transfected COS‐7 cells. Relative to wild‐type VWF, recombinant Arg543Leu VWF showed a similar multimer composition but exhibited binding to fixed platelets both in the presence and absence of ristocetin, confirming the ability of this mutation to permit spontaneous interaction of VWF with platelets. These studies are consistent with a recently proposed model in which the VWF‐A1 domain exists in either ‘on’ or ‘off’ states, with type 2B mutations switching VWF to an ‘on’ state to facilitate GPIb binding.</abstract><cop>Oxford, U.K. and Cambridge, USA</cop><pub>Blackwell Science Ltd</pub><pmid>10233434</pmid><doi>10.1111/j.1365-2141.1999.01358.x</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0007-1048 |
ispartof | British journal of haematology, 1999-05, Vol.105 (2), p.538-541 |
issn | 0007-1048 1365-2141 |
language | eng |
recordid | cdi_proquest_miscellaneous_69774982 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Wiley Free Content |
subjects | Biological and medical sciences Female Hematologic and hematopoietic diseases Hematology Hemostasis Heterozygote Humans Medical sciences Middle Aged mutation Mutation, Missense - genetics Platelet diseases and coagulopathies recombinant von Willebrand Diseases - blood von Willebrand Diseases - genetics von Willebrand Factor - genetics VWD type 2B VWF |
title | Identification and characterization of a novel mutation in von Willebrand factor causing type 2B von Willebrand's disease |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T19%3A26%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Identification%20and%20characterization%20of%20a%20novel%20mutation%20in%20von%20Willebrand%20factor%20causing%20type%202B%20von%20Willebrand's%20disease&rft.jtitle=British%20journal%20of%20haematology&rft.au=Facey,%20David%20A.&rft.date=1999-05&rft.volume=105&rft.issue=2&rft.spage=538&rft.epage=541&rft.pages=538-541&rft.issn=0007-1048&rft.eissn=1365-2141&rft.coden=BJHEAL&rft_id=info:doi/10.1111/j.1365-2141.1999.01358.x&rft_dat=%3Cproquest_cross%3E41823800%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=198590216&rft_id=info:pmid/10233434&rfr_iscdi=true |